Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolving Paradigms in the Treatment of Philadelphia Chromosome-Positive ALL.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.

Blood·2026
Same author

Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT.

Transplantation and cellular therapy·2026
Same author

HDAC7 is a key factor for the germinal center reaction and its underexpression is associated with DLBCL prognosis.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Validation of prognostic scores in patients with HIV-related diffuse large B-cell lymphoma: The value of peripheral blood parameters-A study from the Spanish Lymphoma Group GELTAMO.

British journal of haematology·2025
Same author

Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWP.

Bone marrow transplantation·2025

Related Experiment Video

Updated: Jul 8, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART.

José-Tomás Navarro, Ferran Vall-Llovera, José-Luis Mate

    Haematologica
    |January 2, 2008
    PubMed
    Summary

    Highly active antiretroviral therapy (HAART) significantly reduced leptomeningeal involvement in systemic non-Hodgkin's lymphoma (NHL) among HIV-infected patients. This suggests HAART can prevent central nervous system (CNS) involvement in NHL.

    More Related Videos

    Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
    13:50

    Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

    Published on: June 11, 2011

    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
    09:54

    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

    Published on: December 3, 2019

    Related Experiment Videos

    Last Updated: Jul 8, 2026

    Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
    23:56

    Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

    Published on: October 31, 2010

    Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
    13:50

    Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

    Published on: June 11, 2011

    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
    09:54

    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

    Published on: December 3, 2019

    Area of Science:

    • Neuro-oncology
    • Infectious diseases
    • Hematology

    Background:

    • Assessing central nervous system (CNS) involvement, specifically primary CNS lymphoma and leptomeningeal disease, in HIV-infected patients with systemic non-Hodgkin's lymphoma (NHL).
    • Evaluating the impact of highly active antiretroviral therapy (HAART) on the incidence of these CNS complications.

    Discussion:

    • The study observed a statistically significant decrease in leptomeningeal involvement in systemic NHL among patients receiving HAART (0/30) compared to those not on HAART (12/87, p=0.023).
    • This finding suggests a potential preventative role for HAART in mitigating CNS complications associated with systemic NHL in the context of HIV infection.

    Key Insights:

    • HAART is associated with a significant reduction in leptomeningeal spread of systemic NHL in HIV-positive individuals.
    • The data indicates that HAART may serve as a protective strategy against CNS involvement in this patient population.

    Outlook:

    • Further research is warranted to elucidate the precise mechanisms by which HAART confers protection against CNS lymphoma.
    • Investigating optimal HAART regimens and their long-term effects on preventing CNS complications in HIV-associated NHL is crucial.